175 related articles for article (PubMed ID: 30449770)
1. Trends in Small-Cell Lung Cancer Survival in 1993-2006 Based on Population-Based Cancer Registry Data in Japan.
Oze I; Ito H; Nishino Y; Hattori M; Nakayama T; Miyashiro I; Matsuo K; Ito Y
J Epidemiol; 2019 Sep; 29(9):347-353. PubMed ID: 30449770
[TBL] [Abstract][Full Text] [Related]
2. Recent Survival Trends in High-Grade Neuroendocrine Neoplasms and Lung Cancer.
Breitling LP; Rinke A; Gress TM
Neuroendocrinology; 2020; 110(3-4):225-233. PubMed ID: 31079108
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials.
Foster NR; Mandrekar SJ; Schild SE; Nelson GD; Rowland KM; Deming RL; Kozelsky TF; Marks RS; Jett JR; Adjei AA
Cancer; 2009 Jun; 115(12):2721-31. PubMed ID: 19402175
[TBL] [Abstract][Full Text] [Related]
4. Survival impact of prophylactic cranial irradiation in small-cell lung cancer in the modern era of magnetic resonance imaging staging.
Lim YJ; Song C; Kim HJ; ;
Radiat Oncol; 2022 Feb; 17(1):26. PubMed ID: 35123531
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcome of small cell lung cancer with pericardial effusion but without distant metastasis.
Niho S; Kubota K; Yoh K; Goto K; Ohmatsu H; Nihei K; Ohe Y; Nishiwaki Y
J Thorac Oncol; 2011 Apr; 6(4):796-800. PubMed ID: 21258253
[TBL] [Abstract][Full Text] [Related]
6. Temporal trends from 1986 to 2008 in overall survival of small cell lung cancer patients.
Schabath MB; Nguyen A; Wilson P; Sommerer KR; Thompson ZJ; Chiappori AA
Lung Cancer; 2014 Oct; 86(1):14-21. PubMed ID: 25115410
[TBL] [Abstract][Full Text] [Related]
7. Clinical predictors of survival in young patients with small cell lung cancer: Results from the California Cancer Registry.
Lara JD; Brunson A; Riess JW; Kelly K; Lara PN; Gandara DR
Lung Cancer; 2017 Oct; 112():165-168. PubMed ID: 29191590
[TBL] [Abstract][Full Text] [Related]
8. A Japanese lung cancer registry study on demographics and treatment modalities in medically treated patients.
Sekine I; Shintani Y; Shukuya T; Takayama K; Inoue A; Okamoto I; Kiura K; Takahashi K; Dosaka-Akita H; Takiguchi Y; Miyaoka E; Okumura M; Yoshino I
Cancer Sci; 2020 May; 111(5):1685-1691. PubMed ID: 32103551
[TBL] [Abstract][Full Text] [Related]
9. Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: a mature follow-up report.
Fetscher S; Brugger W; Engelhardt R; Kanz L; Hasse J; Frommhold H; Lange W; Mertelsmann R
Ann Oncol; 1999 May; 10(5):561-7. PubMed ID: 10416006
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC): the importance of smoking history, socioeconomic and marital statuses, and ethnicity.
Ou SH; Ziogas A; Zell JA
J Thorac Oncol; 2009 Jan; 4(1):37-43. PubMed ID: 19096304
[TBL] [Abstract][Full Text] [Related]
11. The impact of reclassifying cancers of unspecified histology on international differences in survival for small cell and non-small cell lung cancer (ICBP SurvMark-2 project).
Morgan E; Arnold M; Rutherford MJ; Bardot A; Ferlay J; De P; Engholm G; Jackson C; Little A; Saint-Jacques N; Walsh P; Woods RR; O'Connell DL; Bray F; Parkin DM; Soerjomataram I
Int J Cancer; 2021 Sep; 149(5):1013-1020. PubMed ID: 33932300
[TBL] [Abstract][Full Text] [Related]
12. Large-Cell Neuroendocrine Carcinoma of the Lung: A Population-Based Study.
Kinslow CJ; May MS; Saqi A; Shu CA; Chaudhary KR; Wang TJC; Cheng SK
Clin Lung Cancer; 2020 Mar; 21(2):e99-e113. PubMed ID: 31601526
[TBL] [Abstract][Full Text] [Related]
13. Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.
Fetscher S; Brugger W; Engelhardt R; Kanz L; Hasse J; Frommhold H; Wenger M; Lange W; Mertelsmann R
Ann Oncol; 1997 Jan; 8(1):49-56. PubMed ID: 9093707
[TBL] [Abstract][Full Text] [Related]
14. Comorbidity in Patients With Small-Cell Lung Cancer: Trends and Prognostic Impact.
Aarts MJ; Aerts JG; van den Borne BE; Biesma B; Lemmens VE; Kloover JS
Clin Lung Cancer; 2015 Jul; 16(4):282-91. PubMed ID: 25572007
[TBL] [Abstract][Full Text] [Related]
15. The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer.
Park JS; Lee JS; Kim EY; Jung JY; Kim SK; Chang J; Kim DJ; Lee CY; Jung I; Kim JH; Kim HR; Moon YW; Kim HS; Cho BC; Shim HS
Lung Cancer; 2015 Jun; 88(3):325-31. PubMed ID: 25819384
[TBL] [Abstract][Full Text] [Related]
16. Educational level, management and outcomes in small-cell lung cancer (SCLC): A population-based cohort study.
Tendler S; Holmqvist M; Wagenius G; Lewensohn R; Lambe M; De Petris L
Lung Cancer; 2020 Jan; 139():111-117. PubMed ID: 31760352
[TBL] [Abstract][Full Text] [Related]
17. Timing of treatment in small-cell lung cancer.
Bhandari S; Pham D; Pinkston C; Oechsli M; Kloecker G
Med Oncol; 2019 Apr; 36(6):47. PubMed ID: 31025131
[TBL] [Abstract][Full Text] [Related]
18. Factors Associated With Treatment Refusal and Impact of Treatment Refusal on Survival of Patients With Small Cell Lung Cancer.
Deviany PE; Ganti AK; Islam KMM
Oncology (Williston Park); 2021 Mar; 35(3):111-118. PubMed ID: 33818051
[TBL] [Abstract][Full Text] [Related]
19. Survival, Chemotherapy Treatments, and Health Care Utilization Among Patients with Advanced Small Cell Lung Cancer: An Observational Study.
He J; Shao C; Hui SL; Zhang Z; Baker J; Dexter PR; Kachroo S; Jin F
Adv Ther; 2020 Jan; 37(1):552-565. PubMed ID: 31828610
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of survival following anti-cancer treatment for small cell lung cancer.
Jones GS; Elimian K; Baldwin DR; Hubbard RB; McKeever TM
Lung Cancer; 2020 Mar; 141():44-55. PubMed ID: 31955000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
